TX-MAVENIR
14.8.2019 14:02:04 CEST | Business Wire | Press release
Mavenir, a leader in accelerating software network transformation and transforming mobile network economics for communications service providers (CSPs), has appointed Aniruddho (Ani) Basu as Senior Vice President and General Manager of Emerging Business, based out of the Stockholm office.
Ani will leverage Mavenir’s existing and newly created solutions for 5G, IoT and digital transformation to generate new business opportunities for Mavenir in Enterprises and Industries. Offerings will include Enriched Communication, IoT and Private Networks, delivered with new business models, via a digital ecosystem of partners and channels.
“This new business focus will enable Mavenir and our channel partners to expand their addressable market, generate new revenues, and create a thriving digital marketplace and ecosystem,” said Pardeep Kohli, President and CEO of Mavenir.
“This is an exciting time as we will power Digital Transformation in Enterprises and Industry Verticals with Advanced Services on our cloud-native, 5G ready platform,” said Basu. “These advanced services will be built and deployed as microservices on elastic infrastructure, through agile DevOps processes, and delivered through Value Added Resellers, System Integrators, Mobile Operators and other Technology Partners.”
Mavenir will offer these propositions via SaaS, PaaS, Neutral Host as well as Asset Ownership business models, and will include applications for Enriched Communication, IoT and Private Networks.
About Mavenir:
Mavenir is the industry's only end-to-end, cloud-native network software provider. Focused on accelerating software network transformation and redefining network economics for Communications Service Providers (CSPs) by offering a comprehensive end-to-end product portfolio across every layer of the network infrastructure stack. From 5G application/service layers to award-winning packet core and RAN – Mavenir leads the way in evolved, cloud-native networking solutions enabling innovative and secure experiences for end users. Leveraging industry-leading firsts in VoLTE, VoWiFi, Advanced Messaging (RCS), Multi-ID, vEPC, and Virtualized RAN, Mavenir accelerates network transformation for more than 250+ CSP customers in over 130 countries, serving over 50% of the world’s subscribers.
We embrace disruptive, innovative technology architectures and business models that drive service agility, flexibility, and velocity. With solutions that propel NFV evolution to achieve web-scale economics, Mavenir offers solutions to help CSPs with cost reduction, revenue generation, and revenue protection. Learn more at mavenir.com .
Mavenir, the M logo, and CloudRange are trademarks owned by Mavenir Systems, Inc.
Copyright © 2019 Mavenir Systems, Inc. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190814005074/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant Group Upgrades LingGuang to 2.0, Turning Its AI Assistant into a Proactive Personal Agent27.10.2026 09:00:00 CET | Press release
Ant Group today announced the launch of LingGuang 2.0, an upgrade that transforms its multimodal AI assistant into a proactive personal agent capable of identifying user needs and managing tasks over time. Moving beyond passive, single-turn interactions, LingGuang 2.0 shifts AI assistance from responding to commands toward continuously identifying needs, following up on tasks, and coordinating everyday affairs on behalf of users. Unlike conventional conversational AI and task-oriented agents, LingGuang 2.0 moves the starting point of AI assistance earlier in the user’s workflow. Instead of waiting for users to issue a command, LingGuang can, with explicit user authorization, draw on connected information and services to spot potential needs, initiate analysis and follow-ups, and alert users when their attention is required. In this way, it evolves from a reactive tool into a personal agent that continuously manages tasks on the user’s behalf. This shift is powered by comprehensive upgr
Unframe Removes Another Barrier Between AI Capabilities and Adoption27.10.2026 09:00:00 CET | Press release
Available through AWS, Google Cloud and Microsoft marketplaces Unframe, the Applied AI Lab, announced its availability on all three leading cloud marketplaces: AWS Marketplace, Google Cloud Marketplace and Microsoft Marketplace. For enterprises, cloud marketplaces have become the preferred channel for discovering and procuring software. AWS, Google Cloud and Microsoft together serve the vast majority of enterprise cloud infrastructure worldwide. Their marketplaces represent a growing share of how organizations purchase technology by consolidating vendor relationships, simplifying contracting and allowing companies to apply existing cloud spend toward new solutions. Being listed across all three is now a key expectation for enterprise-grade software vendors. “Enterprises shouldn’t have to choose between moving quickly on AI and working within the procurement and cloud frameworks they already have,” said Jacquelyn Goldberg, Global VP of Revenue at Unframe. “As an applied AI lab, our job
Institutional Investors and Wealth Advisors Remain Bullish on Private Markets, With a Sharpened Focus on Liquidity: New Report From BBH Investor Services27.10.2026 09:00:00 CET | Press release
84% of investors* plan to increase their private market investments within the next two yearsPrivate equity and private credit rank highest in asset class strategies for growth66% prefer to deploy capital for four to six years, underscoring preference for greater liquidity and access to capital Private markets are growing in importance to investors’ overall portfolios, according to new research from Brown Brothers Harriman (BBH) Investor Services today. In BBH’s second annual Private Markets Investor Survey, over a quarter of investors say more than 30% of their investments will be allocated to private markets strategies in the next five years. Most investors (84%) plan to increase their private markets investments within the next two years, with private equity ranking as the top target for new investment (54%), up 16 points from last year, followed by private credit (44%), up 20 points year-over-year. The survey captures the views of 500 institutional investors and wealth advisors in
SES and CANAL+ Strengthen Strategic Partnership Through 204027.10.2026 08:50:00 CET | Press release
SES and CANAL+, the global media and entertainment group, have extended their strategic partnership through 2040 with a multi-year agreement covering capacity across Europe, Africa and the Caribbean. Under the renewed agreement, CANAL+ will leverage SES’s satellite infrastructure across several orbital positions to deliver premium video and pay TV services to a global subscriber base that now exceeds 40 million viewers across 70 countries. "SES has been a trusted partner for more than 30 years, helping us deliver premium content to millions of viewers across Europe and Africa. This new agreement supports our long-term growth and provides the flexibility and reliability required as we continue to expand our international footprint and serve an increasingly diverse subscriber base," said Stéphane Baumier, Chief Technology Officer of CANAL+. "CANAL+ is one of SES's most valued and longest-standing customers. This agreement demonstrates the enduring importance of satellite in reliably deli
Enhertu® Approved in the EU as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer27.10.2026 08:30:00 CET | Press release
Approval based on DESTINY-Breast05 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 First EU approval of Enhertu in the curative-intent early breast cancer setting Third approval for Enhertu in the EU in four months Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom